Global Retirement Partners’s Pacific Biosciences PACB Stock Holding History

Global Retirement Partners’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$442	Buy	+263	New	+$382	﹤0.01%	4306
2025 Q4	$529	Buy	283 +168	+146%	+$323	﹤0.01%	3989
2025 Q3	$147	Hold	115	–	–	﹤0.01%	3762
2025 Q2	$143	Buy	+115	New	+$133	﹤0.01%	3697
2024 Q4	$580	Hold	317	–	–	﹤0.01%	3375
2024 Q3	$539	Hold	317	–	–	﹤0.01%	3259
2024 Q2	$434	Buy	317 +115	+57%	+$232	﹤0.01%	3320
2024 Q1	$758	Sell	202 -36	-15%	-$211	﹤0.01%	3039
2023 Q4	$1.53K	Buy	238 +36	+18%	+$294	﹤0.01%	2770
2023 Q3	$1.62K	Hold	202	–	–	﹤0.01%	2612
2023 Q2	$2.69K	Hold	202	–	–	﹤0.01%	2429
2023 Q1	$2.37K	Buy	+202	New	+$2.01K	﹤0.01%	2437

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Global Retirement Partners's PACB Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Pacific Biosciences (PACB) in Q2 2026: 263 shares worth $442. The stake represents ﹤0.01% of the portfolio and ranks #4306 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PACB as recently as Q4 2025.

Global Retirement Partners first reported a position in PACB in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.69K in Q2 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Global Retirement Partners held 263 shares of Pacific Biosciences worth $442 as of Q2 2026.
Pacific Biosciences was a new Global Retirement Partners position in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4306 holding.
Global Retirement Partners first reported a position in Pacific Biosciences in Q1 2023 and has held it in 12 quarters since.
Global Retirement Partners's Pacific Biosciences position peaked at $2.69K in Q2 2023.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.